Citations

Showing 10 of 107966 citations.

Monoamine transporters
Benarroch, Eduardo E.

Mayo Clinic

Neurology | August 1, 2013 | Volume: 81 | Issue: 8 | Pages: 761-768

10.1212/wnl.0b013e3182a1ab4a | PMID 23902707 Get It

Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study
Amarasingham, Ruben, Patel, Parag C. , Toto, Kathleen H., Nelson, Lauren L., Swanson, Timothy S. , Moore, Billy J. , Xie, Bin , Zhang, Song , Alvarez, Kristin , Ma, Ying , Kollipara, Usha K., Drazner, Mark H. , Halm, Ethan A. , Alvarez, Kristin

Mayo Clinic

BMJ Quality & Safety | August 1, 2013 | Volume: 22 | Issue: 12 | Pages: 998-1005

10.1136/bmjqs-2013-001901 | PMID 23904506 Get It

Objective To test a multidisciplinary approach to reduce heart failure (HF) readmissions that tailors the intensity of care transition intervention to the risk of the patient using a suite of electronic medical record (EMR)-enabled programmes. Methods A prospective controlled before and after study of adult inpatients admitted with HF and two concurrent control conditions (acute myocardial infarction (AMI) and pneumonia (PNA)) was performed between 1 December 2008 and 1 December 2010 at a large urban public teaching hospital. An EMR-based software platform stratified all patients admitted with HF on a daily basis by their 30-day readmission risk using a published electronic predictive model. Patients at highest risk received an intensive set of evidence-based interventions designed to reduce readmission using existing resources. The main outcome measure was readmission for any cause and to any hospital within 30 days of discharge. Results There were 834 HF admissions in the pre-intervention period and 913 in the post-intervention period. The unadjusted readmission rate declined from 26.2% in the pre-intervention period to 21.2% in the post-intervention period (p=0.01), a decline that persisted in adjusted analyses (adjusted OR (AOR)=0.73; 95% CI 0.58 to 0.93, p=0.01). In contrast, there was no significant change in the unadjusted and adjusted readmission rates for PNA and AMI over the same period. There were 45 fewer readmissions with 913 patients enrolled and 228 patients receiving intervention, resulting in a number needed to treat (NNT) ratio of 20. Conclusions An EMR-enabled strategy that targeted scarce care transition resources to high-risk HF patients significantly reduced the risk-adjusted odds of readmission.
Assessment of in vivo laser ablation using MR elastography with an inertial driver
Woodrum, David A. , Glaser, Kevin J. , Murphy, Matthew C. , Gorny, Krzysztof R. , Chen, Jun , Ehman, Richard L.

Mayo Clinic

Magnetic Resonance in Medicine | July 31, 2013 | Volume: 72 | Issue: 1 | Pages: 59-67

10.1002/mrm.24891 | PMID 23904298 Get It

Investigating Social Ecological Contributors to Diabetes within Hispanics in an Underserved U.S.-Mexico Border Community
Chang, Jean , Guy, Mignonne C. , Rosales, Cecilia , Zapien, Jill Guernsey de , Staten, Lisa K. , Carvajal, Scott C., Fernández, María Virginia Pinzón

Mayo Clinic

International Journal of Environmental Research and Public Health | July 31, 2013 | Volume: 10 | Issue: 8 | Pages: 3217-3232

10.3390/ijerph10083217 | PMID 23912202 Get It

Hispanics bear a disproportionate burden of diabetes in the United States, yet relations of structural, socio-cultural and behavioral factors linked to diabetes are not fully understood across all of their communities. The current study examines disparities and factors associated with diabetes in adult Hispanics of Mexican-descent (N = 648) participating in a population survey of an underserved rural U.S.-Mexico border community. The overall rate of diabetes prevalence rate in the sample, based on self-report and a glucose testing, was 21%; much higher than rates reported for U.S. adults overall, for all Hispanic adults, or for Mexican American adults specifically. Acculturation markers and social determinants of health indicators were only significantly related to diabetes in models not accounting for age. Older age, greater BMI (>30), greater waist-to-hip ratio as well as lower fruit and vegetable consumption were significantly related to increased likelihood of diabetes when all structural, cultural, behavioral, and biological factors were considered. Models with sets of behavioral factors and biological factors each significantly improved explanation of diabetes relative to prior social ecological theory-guided models. The findings show a critical need for diabetes prevention efforts in this community and suggest that health promotion efforts should particularly focus on increasing fruit and vegetable consumption.
Robot-Assisted Radical Nephrectomy and Inferior Vena Cava Tumor Thrombectomy
Grimsby, Gwen M. , Stone, William M., Castle, Erik P.

Mayo Clinic

Videourology™ | July 31, 2013 | Volume: 27 | Issue: 5 | Pages: No page available

10.1089/vid.2013.0019 Get It

SAGE-Journals-Accessible-Video-Player 10.1089/vid.2013.0019.M1 sj-vid-1-vid-10.1089_vid.2013.0019
Stent Revascularization Restores Cortical Blood Flow and Reverses Tissue Hypoxia in Atherosclerotic Renal Artery Stenosis but Fails to Reverse Inflammatory Pathways or Glomerular Filtration Rate
Saad, Ahmed , Herrmann, Sandra M. , Crane, John A., Glockner, James F., McKusick, Michael A., Misra, Sanjay , Eirin, Alfonso , Ebrahimi, Behzad , Lerman, Lilach O. , Textor, Stephen C., Misra, Sanjay , Herrmann, Sandra M , Eirin, Alfonso

Mayo Clinic

Circulation: Cardiovascular Interventions | July 31, 2013 | Volume: 6 | Issue: 4 | Pages: 428-435

10.1161/circinterventions.113.000219 | PMID 23899868 Get It

Background— Atherosclerotic renal artery stenosis (ARAS) is known to reduce renal blood flow, glomerular filtration rate (GFR) and amplify kidney hypoxia, but the relationships between these factors and tubulointerstitial injury in the poststenotic kidney are poorly understood. The purpose of this study was to examine the effect of renal revascularization in ARAS on renal tissue hypoxia and renal injury. Methods and Results— Inpatient studies were performed in patients with ARAS (n=17; >60% occlusion) before and 3 months after stent revascularization, or in patients with essential hypertension (n=32), during fixed Na + intake and angiotensin converting enzyme/angiotensin receptors blockers Rx. Single kidney cortical, medullary perfusion, and renal blood flow were measured using multidetector computed tomography, and GFR by iothalamate clearance. Tissue deoxyhemoglobin levels ( R 2 *) were measured by blood oxygen level–dependent MRI at 3T, as was fractional kidney hypoxia (percentage of axial area with R 2 *>30/s). In addition, we measured renal vein levels of neutrophil gelatinase–associated lipocalin, monocyte chemoattractant protein-1, and tumor necrosis factor-α. Pre-stent single kidney renal blood flow, perfusion, and GFR were reduced in the poststenotic kidney. Renal vein neutrophil gelatinase–associated lipocalin, tumor necrosis factor-α, monocyte chemoattractant protein-1, and fractional hypoxia were higher in untreated ARAS than in essential hypertension. After stent revascularization, fractional hypoxia fell ( P <0.002) with increased cortical perfusion and blood flow, whereas GFR and neutrophil gelatinase–associated lipocalin, monocyte chemoattractant protein-1, and tumor necrosis factor-α remained unchanged. Conclusions— These data demonstrate that despite reversal of renal hypoxia and partial restoration of renal blood flow after revascularization, inflammatory cytokines and injury biomarkers remained elevated and GFR failed to recover in ARAS. Restoration of vessel patency alone failed to reverse tubulointerstitial damage and partly explains the limited clinical benefit of renal stenting. These results identify potential therapeutic targets for recovery of kidney function in renovascular disease.
Transcatheter Aortic Valve Replacement in Patients with Cirrhosis
Greason, Kevin L. , Mathew, Verghese, Wiesner, Russel H., Suri, Rakesh M. , Rihal, Charanjit S. , Rihal, Charanjit S.

Mayo Clinic

Journal of Cardiac Surgery | July 31, 2013 | Volume: 28 | Issue: 5 | Pages: 492-495

10.1111/jocs.12177 | PMID 23899420 Get It

‘Popcorn thrombus’: a case of massive intracardiac thromboembolism
Driver, Steven, Jouni, Hayan, McCully, Robert B. , Driver, Steven L

Mayo Clinic

Heart | July 31, 2013 | Volume: 100 | Issue: 6 | Pages: 520-521

10.1136/heartjnl-2013-304582 | PMID 23899785 Get It

AARC Clinical Practice Guideline: Blood Gas Analysis and Hemoximetry: 2013
Davis, Michael D. , Walsh, Brian K , Sittig, Steve E, Sittig, Steven E., Restrepo, Ruben D

Mayo Clinic

Respiratory Care | July 31, 2013 | Volume: 58 | Issue: 10 | Pages: 1694-1703

10.4187/respcare.02786 | PMID 23901131 Get It

We searched MEDLINE, CINAHL, and Cochrane Library database for articles published between January 1990 and December 2012. The update of this clinical practice guideline is based on 237 clinical trials, 54 reviews, and 23 meta-analyses on blood gas analysis (BGA) and hemoximetry. The following recommendations are made following the Grading of Recommendations Assessment, Development, and Evaluation scoring system. BGA and hemoximetry are recommended for evaluating a patient's ventilatory, acid-base, and/or oxygenation status. BGA and hemoximetry are suggested for evaluating a patient's response to therapeutic interventions. BGA and hemoximetry are recommended for monitoring severity and progression of documented cardiopulmonary disease processes. Hemoximetry is recommended to determine the impact of dyshemoglobins on oxygenation. Capillary BGA is not recommended to determine oxygenation status. Central venous BGA and hemoximetry are suggested to determine oxygen consumption in the setting of early goal-directed therapies. For the assessment of oxygenation, a peripheral venous P O 2 is not recommended as a substitute for an arterial blood measurement (P aO 2 ). It is not recommended to use venous P CO 2 and pH as a substitute for arterial blood measurement of P aCO 2 and pH. It is suggested that hemoximetry is used in the detection and evaluation of shunts during diagnostic cardiac catheterization.
Denosumab Chemotherapy for Recurrent Giant-Cell Tumor of Bone: A Case Report of Neoadjuvant Use Enabling Complete Surgical Resection
Agarwal, Amit , Larsen, Brandon T. , Buadu, Lawrence Danso, Dunn, Jack , Crawford, Russell M. , Bishop, Maria C., Daniel, Jonathan C.

Mayo Clinic

Case Reports in Oncological Medicine | July 30, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-4

10.1155/2013/496351 | PMID 23984138 Get It

Giant-cell tumor of the bone (GCTB) is a rare neoplasm that affects young adults. The tumor is generally benign but sometimes can be locally aggressive. There are no standardized approaches to the treatment of GCTB. Recently, the RANKL inhibitor denosumab has shown activity in this tumor type. We present the case of a young female who presented with locally advanced disease and was successfully managed with the neoadjuvant use of denosumab allowing for surgical resection of the tumor that was previously deemed unresectable. Following surgery, the patient is being managed with continued use of denosumab as ‘maintenance,’ and she continues to be free of disease. Our case highlights a novel approach for the management of locally advanced and aggressive giant cell tumor of the bone.